Trial of Atezolizumab and Bevacizumab With SRF388 or Placebo in Patients With Hepatocellular Carcinoma
Coherus Oncology, Inc.
Coherus Oncology, Inc.
Merck Sharp & Dohme LLC
Ipsen
NeoImmuneTech
Akeso
Eisai Inc.
Bayer
Elevar Therapeutics
ImmunityBio, Inc.
Lokon Pharma AB
Intima Bioscience, Inc.
Jiangsu HengRui Medicine Co., Ltd.
BeOne Medicines
Next Biomedical Co., Ltd.
Amgen
CStone Pharmaceuticals
Jiangsu HengRui Medicine Co., Ltd.
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Merck Sharp & Dohme LLC
Syndax Pharmaceuticals
Novartis
SN BioScience
Cue Biopharma
SOFIE
NovoCure Ltd.
Boehringer Ingelheim
Lumicell, Inc.
Daiichi Sankyo
AstraZeneca
AstraZeneca
RemeGen Co., Ltd.
Pierre Fabre Medicament
Jacobio Pharmaceuticals Co., Ltd.
Freenome Holdings Inc.
Bristol-Myers Squibb
Hoffmann-La Roche
I-Mab Biopharma US Limited
Genome & Company
Hoffmann-La Roche
Seagen Inc.
Hoffmann-La Roche
Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
iOMEDICO AG
Bristol-Myers Squibb
Bristol-Myers Squibb
Hutchmed
Nihon Medi-Physics Co., Ltd.
NantCell, Inc.
Hoffmann-La Roche